default author photo

Paul Mazet

University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT)

SCHOLARLY PAPERS

1

DOWNLOADS

73

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Non-adjuvanted CD40-targeting SARS-CoV-2 Vaccines Induce Broad Long-lasting Protection in Non-human Primates

Number of pages: 48 Posted: 19 Sep 2025
University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Université Paris Est Créteil, University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), University of Bordeaux - ISPED, INSERM U1219, Inria BSO, University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Université Paris Est Créteil, University of Lausanne - Service of Immunology and Allergy, University of Nantes - INSERM, University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Henri-Mondor/Albert-Chenevier Hospital - Vaccine Research Institute, University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Université Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and bacterial diseases (IMVA-HB/IDMIT), University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), University of Lausanne - Service of Immunology and Allergy, University of Bordeaux - SISTM team, UMR 1219, University of Bordeaux - SISTM team, UMR 1219, Henri-Mondor/Albert-Chenevier Hospital - Vaccine Research Institute, Henri-Mondor/Albert-Chenevier Hospital - Vaccine Research Institute, University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT) and University of Claude Bernard Lyon 1 - Inserm
Downloads 73 (867,774)

Abstract:

Loading...

Preclinical study, Immunogenicity, SARS-CoV-2 vaccine candidate, Non-Human Primate, dendritic cell targeting vaccine, CD40